Switch to:
Also traded in: Germany, Thailand

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 1.49
BUGDF's Cash to Debt is ranked higher than
65% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. BUGDF: 1.49 )
Ranked among companies with meaningful Cash to Debt only.
BUGDF' s Cash to Debt Range Over the Past 10 Years
Min: 0.24  Med: 1.25 Max: N/A
Current: 1.49
Equity to Asset 0.61
BUGDF's Equity to Asset is ranked higher than
71% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. BUGDF: 0.61 )
Ranked among companies with meaningful Equity to Asset only.
BUGDF' s Equity to Asset Range Over the Past 10 Years
Min: 0.47  Med: 0.56 Max: 0.66
Current: 0.61
0.47
0.66
Interest Coverage N/A
BUGDF's Interest Coverage is ranked higher than
86% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.52 vs. BUGDF: N/A )
Ranked among companies with meaningful Interest Coverage only.
BUGDF' s Interest Coverage Range Over the Past 10 Years
Min: 10.08  Med: 16.97 Max: N/A
Current: N/A
F-Score: 6
Z-Score: 11.89
M-Score: -2.53
WACC vs ROIC
3.95%
32.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 23.81
BUGDF's Operating margin (%) is ranked higher than
93% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. BUGDF: 23.81 )
Ranked among companies with meaningful Operating margin (%) only.
BUGDF' s Operating margin (%) Range Over the Past 10 Years
Min: 15.24  Med: 19.84 Max: 26.11
Current: 23.81
15.24
26.11
Net-margin (%) 19.35
BUGDF's Net-margin (%) is ranked higher than
89% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. BUGDF: 19.35 )
Ranked among companies with meaningful Net-margin (%) only.
BUGDF' s Net-margin (%) Range Over the Past 10 Years
Min: 12.85  Med: 15.98 Max: 19.9
Current: 19.35
12.85
19.9
ROE (%) 27.06
BUGDF's ROE (%) is ranked higher than
89% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. BUGDF: 27.06 )
Ranked among companies with meaningful ROE (%) only.
BUGDF' s ROE (%) Range Over the Past 10 Years
Min: 21.81  Med: 27.25 Max: 40.25
Current: 27.06
21.81
40.25
ROA (%) 16.20
BUGDF's ROA (%) is ranked higher than
91% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. BUGDF: 16.20 )
Ranked among companies with meaningful ROA (%) only.
BUGDF' s ROA (%) Range Over the Past 10 Years
Min: 14.04  Med: 15.24 Max: 22.77
Current: 16.2
14.04
22.77
ROC (Joel Greenblatt) (%) 40.65
BUGDF's ROC (Joel Greenblatt) (%) is ranked higher than
71% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. BUGDF: 40.65 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
BUGDF' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 32.03  Med: 37.74 Max: 54.69
Current: 40.65
32.03
54.69
Revenue Growth (3Y)(%) 11.00
BUGDF's Revenue Growth (3Y)(%) is ranked higher than
64% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. BUGDF: 11.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
BUGDF' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.6  Med: 11.1 Max: 19.1
Current: 11
4.6
19.1
EBITDA Growth (3Y)(%) 9.20
BUGDF's EBITDA Growth (3Y)(%) is ranked higher than
58% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. BUGDF: 9.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
BUGDF' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.8  Med: 12.55 Max: 20.6
Current: 9.2
-1.8
20.6
EPS Growth (3Y)(%) 10.30
BUGDF's EPS Growth (3Y)(%) is ranked higher than
58% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. BUGDF: 10.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
BUGDF' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 13.8 Max: 27
Current: 10.3
-7.8
27
» BUGDF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with BUGDF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Bumrungrad Hospital PCL

SymbolPriceYieldDescription
BH-P.Thailand40.250.00Pfd shs

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:ACHC, NYSE:HLS, NAS:AMSG, NAS:WOOF, OTCPK:NMHLY, OTCPK:HHCSY, OTCPK:CAKFY, OTCPK:LTGHY, NYSE:MD, NAS:LPNT, NYSE:CHE, NYSE:THC, OTCPK:SKHCF, NAS:SCAI, NYSE:SEM, NAS:AMED, NYSE:AHS, NYSE:CYH, NAS:PAHC, NYSE:ADPT » details
Traded in other countries:BZ7A.Germany, BH-P-R.Thailand,
Bumrungrad Hospital PLC is engaged in hospital business, investment in other companies and rental of properties service in Thailand.

Bumrungrad Hospital PLC is a public company incorporated in Thailand on 21st April, 1975. The Company is engaged in hospital business, investment in other companies and rental of property service in Thailand. The Company provides complete healthcare services for both outpatients and inpatients and also invest in the related health care services businesses in Asian region.

Ratios

vs
industry
vs
history
P/E(ttm) 43.84
BUGDF's P/E(ttm) is ranked lower than
78% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 24.63 vs. BUGDF: 43.84 )
Ranked among companies with meaningful P/E(ttm) only.
BUGDF' s P/E(ttm) Range Over the Past 10 Years
Min: 10.17  Med: 27.5 Max: 62.79
Current: 43.84
10.17
62.79
PE(NRI) 43.84
BUGDF's PE(NRI) is ranked lower than
78% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 25.18 vs. BUGDF: 43.84 )
Ranked among companies with meaningful PE(NRI) only.
BUGDF' s PE(NRI) Range Over the Past 10 Years
Min: 10.17  Med: 27.5 Max: 62.79
Current: 43.84
10.17
62.79
Price/Owner Earnings (ttm) 56.80
BUGDF's Price/Owner Earnings (ttm) is ranked lower than
81% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 25.21 vs. BUGDF: 56.80 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
BUGDF' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 25.72  Med: 43.48 Max: 79.96
Current: 56.8
25.72
79.96
P/B 9.42
BUGDF's P/B is ranked lower than
95% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. BUGDF: 9.42 )
Ranked among companies with meaningful P/B only.
BUGDF' s P/B Range Over the Past 10 Years
Min: 3.7  Med: 6.78 Max: 14.75
Current: 9.42
3.7
14.75
P/S 8.50
BUGDF's P/S is ranked lower than
91% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. BUGDF: 8.50 )
Ranked among companies with meaningful P/S only.
BUGDF' s P/S Range Over the Past 10 Years
Min: 2.59  Med: 5.32 Max: 12.24
Current: 8.5
2.59
12.24
PFCF 66.17
BUGDF's PFCF is ranked lower than
81% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. BUGDF: 66.17 )
Ranked among companies with meaningful PFCF only.
BUGDF' s PFCF Range Over the Past 10 Years
Min: 17.21  Med: 48.41 Max: 96.7
Current: 66.17
17.21
96.7
POCF 35.47
BUGDF's POCF is ranked lower than
86% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. BUGDF: 35.47 )
Ranked among companies with meaningful POCF only.
BUGDF' s POCF Range Over the Past 10 Years
Min: 13.74  Med: 24.46 Max: 53.92
Current: 35.47
13.74
53.92
EV-to-EBIT 29.55
BUGDF's EV-to-EBIT is ranked lower than
72% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 20.23 vs. BUGDF: 29.55 )
Ranked among companies with meaningful EV-to-EBIT only.
BUGDF' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.5  Med: 23 Max: 50.1
Current: 29.55
14.5
50.1
EV-to-EBITDA 23.45
BUGDF's EV-to-EBITDA is ranked lower than
73% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 14.64 vs. BUGDF: 23.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
BUGDF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.2  Med: 18.1 Max: 39.8
Current: 23.45
11.2
39.8
PEG 2.75
BUGDF's PEG is ranked higher than
50% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. BUGDF: 2.75 )
Ranked among companies with meaningful PEG only.
BUGDF' s PEG Range Over the Past 10 Years
Min: 1  Med: 2.87 Max: 3.77
Current: 2.75
1
3.77
Current Ratio 2.62
BUGDF's Current Ratio is ranked higher than
84% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. BUGDF: 2.62 )
Ranked among companies with meaningful Current Ratio only.
BUGDF' s Current Ratio Range Over the Past 10 Years
Min: 0.45  Med: 2.62 Max: 4.16
Current: 2.62
0.45
4.16
Quick Ratio 2.55
BUGDF's Quick Ratio is ranked higher than
84% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. BUGDF: 2.55 )
Ranked among companies with meaningful Quick Ratio only.
BUGDF' s Quick Ratio Range Over the Past 10 Years
Min: 0.42  Med: 2.55 Max: 4.04
Current: 2.55
0.42
4.04
Days Inventory 10.32
BUGDF's Days Inventory is ranked higher than
68% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. BUGDF: 10.32 )
Ranked among companies with meaningful Days Inventory only.
BUGDF' s Days Inventory Range Over the Past 10 Years
Min: 10.32  Med: 12.29 Max: 13.42
Current: 10.32
10.32
13.42
Days Sales Outstanding 47.27
BUGDF's Days Sales Outstanding is ranked lower than
55% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. BUGDF: 47.27 )
Ranked among companies with meaningful Days Sales Outstanding only.
BUGDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.31  Med: 34.6 Max: 48.08
Current: 47.27
20.31
48.08

Buy Back

vs
industry
vs
history
Dividend Growth (3y) 19.80
BUGDF's Dividend Growth (3y) is ranked higher than
64% of the 73 Companies
in the Global Medical Care industry.

( Industry Median: 14.50 vs. BUGDF: 19.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
BUGDF' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -81.5  Med: 13.85 Max: 61.6
Current: 19.8
-81.5
61.6
Yield on cost (5-Year) 4.76
BUGDF's Yield on cost (5-Year) is ranked higher than
97% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. BUGDF: 4.76 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
BUGDF' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 3.71  Med: 7.25 Max: 20.36
Current: 4.76
3.71
20.36

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 54.27
BUGDF's Price/Net Current Asset Value is ranked lower than
92% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 10.67 vs. BUGDF: 54.27 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
BUGDF' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 54.27  Med: 85.78 Max: 3208.33
Current: 54.27
54.27
3208.33
Price/Tangible Book 9.63
BUGDF's Price/Tangible Book is ranked lower than
84% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. BUGDF: 9.63 )
Ranked among companies with meaningful Price/Tangible Book only.
BUGDF' s Price/Tangible Book Range Over the Past 10 Years
Min: 4  Med: 6.81 Max: 13.41
Current: 9.63
4
13.41
Price/Projected FCF 3.93
BUGDF's Price/Projected FCF is ranked lower than
88% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. BUGDF: 3.93 )
Ranked among companies with meaningful Price/Projected FCF only.
BUGDF' s Price/Projected FCF Range Over the Past 10 Years
Min: 3.93  Med: 4.5 Max: 5.65
Current: 3.93
3.93
5.65
Price/DCF (Earnings Based) 2.56
BUGDF's Price/DCF (Earnings Based) is ranked lower than
90% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. BUGDF: 2.56 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.60
BUGDF's Price/Median PS Value is ranked lower than
80% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. BUGDF: 1.60 )
Ranked among companies with meaningful Price/Median PS Value only.
BUGDF' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.52  Med: 0.99 Max: 2.05
Current: 1.6
0.52
2.05
Price/Peter Lynch Fair Value 3.21
BUGDF's Price/Peter Lynch Fair Value is ranked lower than
68% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 2.33 vs. BUGDF: 3.21 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
BUGDF' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 1.1  Med: 2.68 Max: 3.6
Current: 3.21
1.1
3.6
Price/Graham Number 4.33
BUGDF's Price/Graham Number is ranked lower than
83% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 2.38 vs. BUGDF: 4.33 )
Ranked among companies with meaningful Price/Graham Number only.
BUGDF' s Price/Graham Number Range Over the Past 10 Years
Min: 1.94  Med: 3.01 Max: 5.77
Current: 4.33
1.94
5.77
Earnings Yield (Greenblatt) (%) 3.40
BUGDF's Earnings Yield (Greenblatt) (%) is ranked lower than
57% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. BUGDF: 3.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BUGDF' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2  Med: 4.4 Max: 6.9
Current: 3.4
2
6.9
Forward Rate of Return (Yacktman) (%) 14.86
BUGDF's Forward Rate of Return (Yacktman) (%) is ranked higher than
68% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.20 vs. BUGDF: 14.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
BUGDF' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.7  Med: 16.9 Max: 31.7
Current: 14.86
1.7
31.7

More Statistics

Revenue (TTM) (Mil) $500.2
EPS (TTM) $ 0.11
Beta1.12
Short Percentage of Float0.00%
52-Week Range $5.71 - 6.18
Shares Outstanding (Mil)728.65

Analyst Estimate

Dec16 Dec17
Revenue (Mil $)
EPS ($) 0.12 0.13
EPS w/o NRI ($) 0.12 0.13
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for BUGDF

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Reviewed Quarter 2 and Consolidated F/S (F45-3) Jul 29 2016
Management Discussion and Analysis Quarter 2 Ending 30-Jun-2016 Jul 29 2016
Financial Statement Quarter 2/2016 Jul 29 2016
The Approval of Interim Dividend Payment (amended subject) Jul 28 2016
Notification of the Resolution of the Board of Directors Meeting No. 3/2016 Jul 28 2016
Notification of Minutes of AGM No.23 on Company Website May 11 2016
Management Discussion and Analysis Quarter 1 Ending 31-Mar-2016 May 09 2016
Financial Statement Quarter 1/2016 May 09 2016
Reviewed Quarter 1 and Consolidated F/S (F45-3) May 09 2016
Resolutions of the Annual General Meeting of Shareholders No.23 for the Year 2016 (amend template) Apr 28 2016
Resolutions of the Annual General Meeting of Shareholders No.23 for the Year 2016 Apr 27 2016
Notification of Notice of Annual General Meeting No.23 for Year 2016 on the Company's website Mar 25 2016
Notification of the right to convert Preferred Shares to Common Shares Jan 11 2016
Opportunity for Shareholders to Propose AGM Agenda Dec 11 2015
Notification of Minutes of EGM 1/2015 on Company website Dec 11 2015
Notification of the Resolutions of the EGM No.1/2015 Nov 30 2015
The Notice of EGM No.1/2015 on the Company's website Nov 06 2015
Management Discussion and Analysis Quarter 3 Ending 30-Sep-2015 Oct 30 2015
Reviewed Quarter 3 and Consolidated F/S (F45-3) Oct 30 2015
Financial Statement Quarter 3/2015 Oct 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)